Nabla – Weekly Recap

Nabla is a clinical AI company focused on ambient documentation tools, and this weekly recap highlights several developments underscoring growing commercial traction and ecosystem alignment. During the week, the company emphasized concrete efficiency gains from deployments and increased visibility alongside a major electronic health record vendor.

Nabla showcased results from its ambient AI implementation at LCMC Health, where clinicians reportedly saw 9% less time in the EHR and 19% less time spent on notes. The deployment also delivered a 22% reduction in after-hours workload and a 2.4% increase in patient visits per day, indicating measurable productivity and capacity benefits for the health system.

These metrics position Nabla’s offering as a tool to reduce administrative burden and support clinician retention by freeing time for patient care. For health systems, the data points suggest the potential to improve throughput and economics without proportional staffing increases, which could strengthen the business case for broader adoption.

Nabla also highlighted its participation in NextGen Healthcare’s FY27 Commercial Kickoff, a forum centered on evolving EHRs from systems of record to AI-enabled systems of context. Chief Clinical Product Officer Dr. Matthew Sakumoto moderated a physician panel on “AI in Action,” featuring real-world ambient AI use cases aimed at reducing after-hours work and mitigating burnout.

Chief Product Officer Laurent Landowski joined a session on NextGen’s Clinical AI roadmap and commercial growth, signaling closer strategic alignment with the EHR vendor’s product and go-to-market plans. While no specific contracts or financial terms were disclosed, this visibility suggests Nabla is being positioned within a broader EHR ecosystem rather than as a standalone point solution.

Taken together, the week’s updates highlight both validated customer outcomes and strengthening ecosystem relationships for Nabla. If similar efficiency results are replicated across additional deployments, the company’s ambient AI platform could see expanded utilization and a more defensible position in the competitive clinical documentation market.